AMETEKAME
About AMETEK
AMETEK is a designer and manufacturer of electronic instruments and electromechanical devices sold into a wide range of industrial and technical end markets. The business is organized into two reporting segments. The Electronic Instruments Group builds advanced monitoring, testing, calibration, and display instruments for process, aerospace, power, and analytical laboratory customers, and it is consistently the larger and more profitable of the two. The Electromechanical Group produces highly engineered electrical connectors, precision motion control products, specialty metals, and thermal management systems for aerospace, defense, medical, and automation customers. Products are typically specified into customer equipment and qualified for long service lives, giving the mix a recurring aftermarket and spares component alongside original equipment sales.
Serious holders track a defined set of structural questions. AMETEK is a serial acquirer, so capital allocation discipline, purchase multiples, and the pace of integration are watched closely; the model depends on buying niche instrument franchises and expanding their margins under a common operating system. End-market cyclicality matters because process, aerospace, and semiconductor demand move on different clocks, and the company's exposure to defense budgets and export-controlled technologies creates regulatory sensitivity. Governance features to monitor include the chief executive succession bench, board independence, and the balance between buybacks, dividends, and reinvestment. Foreign exchange translation is a persistent variable given significant non-U.S. sales.
The company traces its lineage to the American Machine and Metals Company, founded in 1930, and adopted the AMETEK name in the 1960s after a series of consolidations of small instrument and motor businesses. A pivotal transformation began in the 1990s under a new management team that shifted the portfolio toward higher-margin differentiated instruments and away from commodity electric motors, funded by a steady program of bolt-on acquisitions. Successive chief executives have continued that playbook, adding franchises across analytical instruments, ultra-precision technologies, and connectivity. AMETEK is incorporated in Delaware, headquartered in Berwyn, Pennsylvania, listed on the New York Stock Exchange, and is a component of the S&P 500.
Revenue is generated by selling engineered instruments and components directly to original equipment manufacturers, process operators, defense primes, laboratories, hospitals, utilities, and research institutions, supplemented by a distributor channel for standard catalog products. Sales are typically won by designing a product into a customer's specification, after which switching costs, qualification requirements, and long equipment lifecycles produce durable aftermarket revenue in service, calibration, spares, and consumables. Competitive position rests on niche technical leadership rather than broad scale, placing AMETEK against diversified peers such as Danaher, Roper, Fortive, and Mettler-Toledo in adjacent categories. International customers account for a substantial share of sales, with Europe and Asia the largest non-U.S. regions.
Company profile by LineVest editorial. Journalism, not investment advice. Commission a full SEC-based report on AMETEK →
AMETEK coverage
No AMETEK stories yet — LineVest publishes U.S. market news daily, and new coverage of AMETEK will appear here automatically.
Browse the latest U.S. market news →Go deeper than the headline
You just read what happened. Here's how to read what it means.
The U.S. market, every morning — free
LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.
Full report on AMETEK
We read AMETEK's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.
$12 · one-time
Get the AMETEK reportFollow the whole market
Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.
$9.99 · monthly
SubscribeIndependent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.